HUTCHISON CHINA/S (HCM) Upgraded at BidaskClub

BidaskClub upgraded shares of HUTCHISON CHINA/S (NASDAQ:HCM) from a hold rating to a buy rating in a research note issued to investors on Monday morning, BidAskClub reports.

Several other research firms also recently commented on HCM. Zacks Investment Research downgraded HUTCHISON CHINA/S from a hold rating to a sell rating in a research report on Thursday, April 11th. HSBC began coverage on HUTCHISON CHINA/S in a research note on Wednesday, March 27th. They issued a buy rating for the company. Finally, Deutsche Bank began coverage on HUTCHISON CHINA/S in a research note on Monday, March 4th. They issued a buy rating and a $26.82 price target for the company. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. HUTCHISON CHINA/S has a consensus rating of Buy and a consensus price target of $26.82.

HUTCHISON CHINA/S stock opened at $26.86 on Monday. The company has a quick ratio of 4.19, a current ratio of 4.33 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $3.56 billion, a price-to-earnings ratio of -47.12 and a beta of 1.04. HUTCHISON CHINA/S has a 12 month low of $20.83 and a 12 month high of $39.68.

Several hedge funds have recently modified their holdings of the company. Tobam increased its stake in shares of HUTCHISON CHINA/S by 67.7% in the first quarter. Tobam now owns 40,901 shares of the company’s stock valued at $1,251,000 after buying an additional 16,516 shares during the period. Hsbc Holdings PLC increased its stake in shares of HUTCHISON CHINA/S by 502.9% in the first quarter. Hsbc Holdings PLC now owns 67,583 shares of the company’s stock valued at $2,067,000 after buying an additional 84,359 shares during the period. Voya Investment Management LLC acquired a new stake in shares of HUTCHISON CHINA/S in the first quarter valued at about $202,000. Geode Capital Management LLC increased its stake in shares of HUTCHISON CHINA/S by 5.8% in the first quarter. Geode Capital Management LLC now owns 121,644 shares of the company’s stock valued at $3,695,000 after buying an additional 6,710 shares during the period. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of HUTCHISON CHINA/S in the first quarter valued at about $416,000. 17.92% of the stock is owned by institutional investors.

HUTCHISON CHINA/S Company Profile

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

Featured Story: Calculate Your Return on Investment (ROI)

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.